Of note, regorafenib abrogated palbociclib-induced expression of cyclin D1, possibly through MAPK and p70S6K signaling inhibition (33), and this might contribute to cell death, as suggested by the previous observation that silencing cyclin D1 promotes apoptosis in HCC cells (73). The gene discussed is RPS6KB1; the disease is hepatocellular carcinoma.